These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9149701)

  • 21. Orally active prostacyclin analogue for cardiovascular disease.
    Nagaya N
    Int Angiol; 2010 Apr; 29(2 Suppl):14-8. PubMed ID: 20357744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease.
    Limsuwan A; Pienvichit P; Khowsathit P
    Pediatr Cardiol; 2005; 26(6):787-91. PubMed ID: 16132278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical therapy of pulmonary hypertension. The prostacyclins.
    Galié N; Manes A; Branzi A
    Clin Chest Med; 2001 Sep; 22(3):529-37, x. PubMed ID: 11590846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
    Scott JP; Higenbottam T; Wallwork J
    Br J Clin Pract; 1990 Jun; 44(6):231-4. PubMed ID: 1698429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treprostinil (Remodulin) for pulmonary arterial hypertension.
    Med Lett Drugs Ther; 2002 Sep; 44(1139):80-2. PubMed ID: 12237619
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction.
    Ono F; Nagaya N; Okumura H; Shimizu Y; Kyotani S; Nakanishi N; Miyatake K
    Chest; 2003 May; 123(5):1583-8. PubMed ID: 12740277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral administration of beraprost sodium did not exacerbate pulmonary hypertension with CREST syndrome].
    Furukawa K; Ikeda S; Obase K; Muroya T; Oka H; Kojima M; Miyahara Y; Kohno S
    Nihon Naika Gakkai Zasshi; 2001 May; 90(5):881-3. PubMed ID: 11460359
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension.
    Ikeda D; Tsujino I; Sakaue S; Ohira H; Itoh N; Kamigaki M; Ishimaru S; Atsumi T; Nishimura M
    Circ J; 2007 Nov; 71(11):1829-31. PubMed ID: 17965512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review.
    Demerouti EA; Manginas AN; Athanassopoulos GD; Karatasakis GT; Leontiadis ED; Pavlides GS
    Respir Care; 2013 Feb; 58(2):e1-5. PubMed ID: 22710078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostanoids in the treatment of pulmonary arterial hypertension].
    Başkurt M; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Jul; 288(1):36. PubMed ID: 12090852
    [No Abstract]   [Full Text] [Related]  

  • 39. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
    Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
    J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beraprost sodium for pulmonary hypertension with congenital heart disease.
    Suzuki H; Sato S; Tanabe S; Hayasaka K
    Pediatr Int; 2002 Oct; 44(5):528-9. PubMed ID: 12225555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.